James Dacombe, a 25-year-old British founder, has become Europe's youngest self-made billionaire after his AI chip company Olix secured a $312 million investment that lifted the firm's valuation to $3.3 billion and his personal stake above the billion-dollar threshold.
Olix's funding round catapults founder's net worth
The London-based chip maker, which designs specialised processors for artificial-intelligence workloads, announced the financing in February. The round, led by a consortium of European and US investors, tripled Olix's market value since its launch two years ago. Olix now stands at a $3.3 billion market capitalisation, and James Dacombe retains roughly 30 percent of the equity, pushing his net worth over $1 billion.
CoMind stake adds to the wealth picture
In addition to Olix, Dacombe holds a 12 percent share in his earlier venture CoMind, a brain-monitoring startup he founded in 2017. CoMind raised $102.5 million in August of last year, further bolstering Dacombe's assets and cementing his place among the world's youngest billionaires.
From school dropout to Thiel Fellow
Dacombe began programming at age 13 while attending Ashville College in Harrogate, North Yorkshire. He left school at 17 to focus on CoMind, and later earned a place in the Thiel Fellowship, a two-year programme founded by Peter Thiel that provides $250,000 to entrepreneurs who skip university. The fellowship has previously supported founders such as ScaleAI's Alexandr Wang and Lucy Guo.
"An advantage of starting my business so young was naivety," Dacombe told The Sunday Times in 2024. "You don't have the scar tissues from what hasn't worked, so you just try a lot of things. Fortunately, some of them work."
Why the milestone matters for Europe
The achievement highlights the growing capacity of European tech ecosystems to nurture high-growth AI companies. While most of the world's youngest billionaires are based in the United States, Dacombe's success demonstrates that UK-based founders can attract substantial capital and reach valuations comparable with Silicon Valley peers.
What lies ahead for the entrepreneur
Olix plans to use the new funds to expand production capacity and accelerate research into next-generation AI processors, aiming to secure contracts with major cloud providers across Europe. Meanwhile, CoMind is developing clinical-grade neuro-monitoring devices, with a rollout slated for early 2027. Observers expect Dacombe to continue leveraging his dual-company portfolio to shape the continent's AI hardware landscape.